PD-L1 interacts with programmed death-1 (PD-1), leading to T cell apoptosis, dysfunction, and exhaustion, thereby inhibiting the activation and proliferation of tumor antigen-specific CD8+ T cells, which facilitates tumor immune escape [187]. The gene discussed is CD274; the disease is neoplasm.